Bleeding in Patients with Antiphospholipid Antibodies
The antiphospholipid antibodies (aPL) are commonly associated with thrombotic events and obstetric complications. However, apart from the bleeding complications of antithrombotic therapy, the acquired coagulopathy caused by the aPL, particularly by lupus anticoagulant and anticardiolipin antibodies,...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76760 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Bleeding in Patients with Antiphospholipid Antibodies
- Antiphospholipid Antibodies in Patients with COVID-19
- Presence of Antibodies Against Mycoplasma penetrans in Patients with Antiphospholipid Syndrome
- Antiphospholipid Antibodies – Detection and Clinical Importance
- The Management of Antiphospholipid Antibodies Affected Pregnancy
- Update on Antiphospholipid Antibody Syndrome Management
- Antiphospholipid Antibodies and Their Association with Atherosclerotic Changes in Patients with Systemic Lupus Erythematosus – Review of Literature and Own Experiences